Kim, S.; Lee, Y.; Bang, S.M.; Bak, H.; Yim, S.Y.; Lee, Y.S.; Yoo, Y.J.; Jung, Y.K.; Kim, J.H.; Seo, Y.S.;
et al. Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients. J. Clin. Med. 2021, 10, 1840.
https://doi.org/10.3390/jcm10091840
AMA Style
Kim S, Lee Y, Bang SM, Bak H, Yim SY, Lee YS, Yoo YJ, Jung YK, Kim JH, Seo YS,
et al. Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients. Journal of Clinical Medicine. 2021; 10(9):1840.
https://doi.org/10.3390/jcm10091840
Chicago/Turabian Style
Kim, Sehwa, Yoonseok Lee, Soo Min Bang, Haein Bak, Sun Young Yim, Young Sun Lee, Yang Jae Yoo, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo,
and et al. 2021. "Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients" Journal of Clinical Medicine 10, no. 9: 1840.
https://doi.org/10.3390/jcm10091840
APA Style
Kim, S., Lee, Y., Bang, S. M., Bak, H., Yim, S. Y., Lee, Y. S., Yoo, Y. J., Jung, Y. K., Kim, J. H., Seo, Y. S., Yim, H. J., Um, S. H., Byun, K. S., & Yeon, J. E.
(2021). Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients. Journal of Clinical Medicine, 10(9), 1840.
https://doi.org/10.3390/jcm10091840